6-Isopropyl-benzothiazol-2-ylamine, 95.0%, 250mg

2-Iodo-4-(methylthio)-7,8-dihydroquinazolin-5(6H)-one, 250mg

N-(1-Naphtyl)-éthylènediamine, dichlorhydrate min. 99%, pa, 25 g, emballage en verre

3-((3R,4R)-3-((2-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)(methyl)amino)-4-methylpiperidin-1-yl)-3-oxopropanenitrile, 95%, 50mg

3-Bromo-5-(trifluoromethyl) pyridine-2-amine, 98.0%, 25g

3,7-Dimethyloct-6-en-1-yl formate, 95.0%, 25g

3-Bromofuran, 97.0%, 5g

6-Azauracil>99.0%(HPLC)(T)5g

N-(2-aminoethyl)-N-ethyl-N-(3-methylphenyl)amine, 98.0%, 25g

Imidazo[1,2-a]pyridine-7-carbaldehyde, 95.0%, 1g

(3-Methoxycyclohexyl)methanol, 98%, 500mg

3-Methoxybicyclo[1.1.1]pentan-1-amine hydrochloride, 98%, 100mg

1,3-Dichloro-1,1,3,3-tetramethyldisiloxane>97.0%(GC)25g